开发和验证LC-MS/MS方法,用于确定法维皮拉维尔纯和片剂剂型
Nandeesha Itigimath1, Hadagali Ashoka2, Basappa C Yallur1
1Ramaiah Institute of Technology, Department of Chemistry, Visvesvaraya Technological University, Bangalore, Belagavi, India.
Turkish journal of pharmaceutical sciences
|August 22, 2023
概括
一种新的液体染色学-并联质谱法 (LC-MS/MS) 方法可以准确地确定药物配方中的法维皮拉维尔 (FVPR). 这种经过验证的方法简单,强大,适合配方行业.
科学领域:
- 分析化学 分析化学
- 药品分析 药品分析
背景情况:
- 费维皮拉维尔 (FVPR) 是一种新型抗病毒药物,需要强大的分析方法来进行质量控制.
- 在药物配方中精确确定FVPR对于治疗疗效和患者安全至关重要.
研究的目的:
- 开发和验证一种简单,准确和可重复的分析方法来确定法维皮拉维尔 (FVPR).
- 建立一种液体染色学-并联质谱法 (LC-MS/MS) 方法,以量化纯和片剂剂型的FVPR.
主要方法:
- 一个Shimpack GISS C18柱被使用了酸和甲醇的梯度移动相.
- LC-MS/MS方法采用了0.4毫升/分钟的流量,总运行时间为5.0分钟.
- 方法验证按照国际协调会议 (ICH) 的指导方针进行.
主要成果:
- 该方法在50-200μg/mL范围内显示出出色的线性 (R2=1.0).
- 检测极限 (LOD) 为4.044微克/毫升,量化极限 (LOQ) 为12.253微克/毫升.
- 高回收率 (99.0-101%) 证实了该方法的准确性和精确性.
结论:
- 开发的LC-MS/MS方法对于FVPR的确定是简单,准确,强大,精确和可重复的.
- 该方法符合ICH指南,适合在制药配方行业采用.
相关概念视频
In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...


